Concepedia

Publication | Closed Access

Erlotinib and Bevacizumab Have Synergistic Activity against Melanoma

DOI

85

Citations

30

References

2009

Year

Nikolaus Schicher, Verena Paulitschke, Alexander Swoboda, Rainer Kunstfeld, Robert Loewe, Peter Pilarski, Hubert Pehamberger, Christoph Höeller
Clinical Cancer Research

Abstract

The presented data strongly support the use of a combination of erlotinib and bevacizumab as a novel treatment regimen for metastatic melanoma.

References

YearCitations

Page 1